Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 18f Fluorodeoxyglucose
2. 18f-fdg
3. 18fdg
4. 2 Fluoro 2 Deoxy D Glucose
5. 2 Fluoro 2 Deoxyglucose
6. 2-fluoro-2-deoxy-d-glucose
7. 2-fluoro-2-deoxyglucose
8. F 18, Fludeoxyglucose
9. F 18, Fluorodeoxyglucose
10. F18, Fluorodeoxyglucose
11. Fluorine 18 Fluorodeoxyglucose
12. Fluorine-18-fluorodeoxyglucose
13. Fluorodeoxyglucose F 18
14. Fluorodeoxyglucose F18
15. Fluorodeoxyglucose, 18f
1. Fludeoxyglucose F18
2. 105851-17-0
3. Fludeoxyglucose (18f)
4. 18fdg
5. Sbt3gbx27w
6. Fludeoxyglucose ((sup 18)f)
7. Chebi:31617
8. (2s,3r,4s,5s,6r)-3-(18f)fluoranyl-6-(hydroxymethyl)oxane-2,4,5-triol
9. (18f)fdg
10. (18f)fluorodeoxyglucose
11. (18f)-fluorodeoxyglucose
12. [18f]fdg
13. Flucis
14. F-18 Fdg
15. 2-deoxy-2-(fluoro-18f)-a-d-glucopyranose
16. Unii-sbt3gbx27w
17. 2-(fluoro-18f)-2-deoxy-alpha-glucopyranose
18. Fludeoxyglucose F(sup 18)
19. Alpha-d-glucopyranose, 2-deoxy-2-(fluoro-18f)-
20. Fludeoxyglucose F 18 (tn)
21. Schembl135994
22. Fludeoxyglucose F 18 (usp)
23. 18dg
24. Chembl1092067
25. (18)fdg
26. Dtxsid50894178
27. [f-18]-fdg
28. Moli000964
29. Fludeoxyglucose F 18 [usan:usp]
30. Fludeoxyglucose (18f) (jan/inn)
31. Akos006272016
32. Fluorine F 18 Fluorodeoxyglucose
33. 2-deoxy-2-((18)f)fluoro-alpha-d-glucose
34. .alpha.-d-fludeoxyglucopyranose F-18
35. 2-(fluoro-(18)f)-2-deoxy-alpha-glucopyranose
36. D01843
37. 2-deoxy-2-((18)f)fluoro-alpha-d-glucopyranose
38. 2-deoxy-2-(fluoro-(18)f)-alpha-d-glucopyranose
39. 851d170
40. Q419849
41. 2-deoxy-2-fluoro-(sup 18)f-alpha-d-glucopyranose
42. Alpha-d-glucopyranose, 2-deoxy-2-(fluoro-(sup 18)f)-
43. .alpha.-d-glucopyranose, 2-deoxy-2-(fluoro-18f)-
44. (2s,3r,4s,5s,6r)-3-(??f)fluoro-6-(hydroxymethyl)oxane-2,4,5-triol
Molecular Weight | 181.15 g/mol |
---|---|
Molecular Formula | C6H11FO5 |
XLogP3 | -1.6 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 181.061586 g/mol |
Monoisotopic Mass | 181.061586 g/mol |
Topological Polar Surface Area | 90.2 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 155 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Fludeoxyglucose f18 |
Active Ingredient | Fludeoxyglucose f-18 |
Dosage Form | Injectable |
Route | Intravenous |
Strength | 4-40mci/ml; 20-240mci/ml; 20-300mci/ml; 20-500mci/ml; 20-200mci/ml; 20-150mci/ml |
Market Status | Prescription |
Company | Feinstein; Essential Isotopes; Ucla Biomedical; Lantheus Medical; Houston Cyclotron; Ucsf Rodiopharm; Ma General Hosp; Wi Medcl Cyclotron; Petnet; Uihc Pet Imaging; Univ Tx Md Anderson; Mcprf; Wusm Cyclotron |
2 of 2 | |
---|---|
Drug Name | Fludeoxyglucose f18 |
Active Ingredient | Fludeoxyglucose f-18 |
Dosage Form | Injectable |
Route | Intravenous |
Strength | 4-40mci/ml; 20-240mci/ml; 20-300mci/ml; 20-500mci/ml; 20-200mci/ml; 20-150mci/ml |
Market Status | Prescription |
Company | Feinstein; Essential Isotopes; Ucla Biomedical; Lantheus Medical; Houston Cyclotron; Ucsf Rodiopharm; Ma General Hosp; Wi Medcl Cyclotron; Petnet; Uihc Pet Imaging; Univ Tx Md Anderson; Mcprf; Wusm Cyclotron |
Radiopharmaceuticals
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)
V - Various
V09 - Diagnostic radiopharmaceuticals
V09I - Tumour detection
V09IX - Other diagnostic radiopharmaceuticals for tumour detection
V09IX04 - Fludeoxyglucose (18F)
Related Excipient Companies
Excipients by Applications
Global Sales Information
ABOUT THIS PAGE
A Fluorodeoxyglucose F18 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluorodeoxyglucose F18, including repackagers and relabelers. The FDA regulates Fluorodeoxyglucose F18 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluorodeoxyglucose F18 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fluorodeoxyglucose F18 supplier is an individual or a company that provides Fluorodeoxyglucose F18 active pharmaceutical ingredient (API) or Fluorodeoxyglucose F18 finished formulations upon request. The Fluorodeoxyglucose F18 suppliers may include Fluorodeoxyglucose F18 API manufacturers, exporters, distributors and traders.
click here to find a list of Fluorodeoxyglucose F18 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fluorodeoxyglucose F18 DMF (Drug Master File) is a document detailing the whole manufacturing process of Fluorodeoxyglucose F18 active pharmaceutical ingredient (API) in detail. Different forms of Fluorodeoxyglucose F18 DMFs exist exist since differing nations have different regulations, such as Fluorodeoxyglucose F18 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fluorodeoxyglucose F18 DMF submitted to regulatory agencies in the US is known as a USDMF. Fluorodeoxyglucose F18 USDMF includes data on Fluorodeoxyglucose F18's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fluorodeoxyglucose F18 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fluorodeoxyglucose F18 suppliers with USDMF on PharmaCompass.
Fluorodeoxyglucose F18 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluorodeoxyglucose F18 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluorodeoxyglucose F18 GMP manufacturer or Fluorodeoxyglucose F18 GMP API supplier for your needs.
A Fluorodeoxyglucose F18 CoA (Certificate of Analysis) is a formal document that attests to Fluorodeoxyglucose F18's compliance with Fluorodeoxyglucose F18 specifications and serves as a tool for batch-level quality control.
Fluorodeoxyglucose F18 CoA mostly includes findings from lab analyses of a specific batch. For each Fluorodeoxyglucose F18 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluorodeoxyglucose F18 may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluorodeoxyglucose F18 EP), Fluorodeoxyglucose F18 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluorodeoxyglucose F18 USP).
LOOKING FOR A SUPPLIER?